Leadership Transition - Dentsply Sirona has appointed Daniel Scavilla as President and CEO, effective August 1, 2025, succeeding Simon Campion who will leave the company on July 31, 2025 [1][3] - Scavilla has over three decades of experience in the medical technology and pharmaceutical industries, previously serving as CEO of Globus Medical and holding various leadership roles at Johnson & Johnson [2][8] - The Board of Directors expresses confidence in Scavilla's ability to enhance shareholder value and lead the company through its transformation [3] Financial Performance - Dentsply Sirona expects to report second quarter 2025 net sales of approximately $935 million, with adjusted earnings per diluted share anticipated to be between $0.50 and $0.52 [5] - The company reaffirmed its 2025 outlook as provided in the May 8, 2025 earnings press release, indicating ongoing confidence in its financial trajectory [6] Company Overview - Dentsply Sirona is the world's largest diversified manufacturer of professional dental products and technologies, with a strong portfolio of brands and a commitment to innovation in dental care [9]

VB Spine is a Strategic Partner to Stryker with Access to Mako Spine and Copilot Marc, John and Anthony Viscogliosi Lead VB Spine as Co-Chief Executive Officers NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Viscogliosi Brothers, LLC, a family-owned investment office specializing in the neuro-musculoskeletal space, today announced the successful completion of its previously announced acquisition of the U.S. spine business from Stryker (NYSE:SYK). The business will operate as a standalone company under the nam ...

VB Spine is a Strategic Partner to Stryker with Access to Mako Spine and Copilot Marc, John and Anthony Viscogliosi Lead VB Spine as Co-Chief Executive Officers NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Viscogliosi Brothers, LLC, a family-owned investment office specializing in the neuro-musculoskeletal space, today announced the successful completion of its previously announced acquisition of the U.S. spine business from Stryker (NYSE: SYK). The business will operate as a standalone company under the na ...